Upperton Pharma Solutions

Activities: Manufacturing Drug Delivery Research & Development

Trending Articles

  1. FDA approves Lilly's oral GLP-1 pill Foundayo for obesity with no food or water restrictions Eli Lilly has received FDA approval for Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight that requires no fasting or...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.
  4. Shimadzu celebrates a 70th anniversary Gas chromatography (GC) product line celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics
  5. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Upperton submits MHRA application for new sterile manufacturing facility in Nottingham

UK CDMO Upperton Pharma Solutions has filed for regulatory approval from the MHRA for its new 7000 sqft sterile manufacturing facility, designed to meet updated EU GMP Annex 1 standards and expand early-phase clinical manufacturing capacity
Manufacturing

Upperton Pharma Solutions wins Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025

The company was also nominated as a finalist for Pharma Company of the Year, marking the second year of success at the Pharma Industry Awards
Finance

Upperton Pharma Solutions advances oral vaccine delivery with Oxford’s Pandemic Sciences Institute

Upperton Pharma Solutions has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford
Manufacturing

Upperton Pharma Solutions expands with new sterile manufacturing facility

New Nottingham-based site enhances aseptic and terminally sterilised drug production
Manufacturing

Upperton Pharma Solutions bolsters UK facility with large-scale processing capabilities

The company can now offer large-scale commercialisation capabilities for a range of dosage forms following a successful MHRA inspection
Manufacturing

Upperton opens novel development and GMP manufacturing facility

The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development capabilities equipped with a pilot plant
Finance

Upperton announces expansion into sterile drug manufacturing with £5m GMP facility

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions has announced a £5m investment to expand its operations into small-scale sterile fill-finish
Subscribe now